首页> 外国专利> Recurrence prognosis and prediction of added benefit of adjuvant chemotherapy in early stage non-small cell lung cancer with radiomic features on baseline computed tomography

Recurrence prognosis and prediction of added benefit of adjuvant chemotherapy in early stage non-small cell lung cancer with radiomic features on baseline computed tomography

机译:具有基线CT放射特征的早期非小细胞肺癌的复发预后和辅助化疗附加效益预测

摘要

Embodiments generate an early stage NSCLC recurrence prognosis, and predict added benefit of adjuvant chemotherapy. Embodiments include processors configured to access a radiological image of a region of tissue demonstrating early stage NSCLC; segment a tumor represented in the radiological image; define a peritumoral region based on a morphological dilation of a boundary of the tumor; extract a radiomic signature that includes a set of tumoral radiomic features extracted from the tumoral region, and a set of peritumoral radiomic features extracted from the peritumoral region, based on a continuous time to event data; compute a radiomic score based on the radiomic signature; compute a probability of added benefit of adjuvant chemotherapy based on the radiomic score; and generate an NSCLC recurrence prognosis based on the radiomic score. Embodiments may display the radiomic score, or generate a personalized treatment plan based on the radiomic score.
机译:实施方案产生早期NSCLC复发预后,并预测辅助化疗的附加益处。实施例包括配置为访问显示早期非小细胞肺癌的组织区域的放射图像的处理器;分割放射图像中显示的肿瘤;根据肿瘤边界的形态扩张定义肿瘤周围区域;基于连续的事件时间数据,提取包括从肿瘤区域提取的一组肿瘤放射特征和从肿瘤周围区域提取的一组肿瘤周围放射特征的放射特征;基于辐射特征计算辐射分数;根据放射评分计算辅助化疗增加益处的概率;并根据放射评分得出非小细胞肺癌复发预后。实施例可以显示放射评分,或者基于放射评分生成个性化治疗计划。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号